Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5528-5539

  Hinkula, Jorma ^a,b   Svanholm, Cecilia ^a   Schwartz, Stefan ^a   Lundholm, Peter ^a   Brytting, Maria ^b   Engström, Gunnel ^b   Benthin, Reinhold ^b   Glaser, Hubertus ^c   Sutter, Gerd ^c   Kohleisen, Birgit ^c   Erfle, Volker ^c   Okuda, Kenji ^d   Wigzell, Hans ^a   Wahren, Britta ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c Institute for Molecular Virology   (Germany)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; INTERLEUKIN 2; NEF PROTEIN; REV PROTEIN; STRUCTURAL PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; REGULATOR GENE; T LYMPHOCYTE ACTIVATION;

EID: 17444447880     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5528-5539.1997     Document Type: Article

References (49)

1. Austyn, J. M. 1992. Antigen uptake and presentation by dendritic leukocytes. Semin. Immunol. 4:227-232.
2. Blazevic, V., A. Ranki, S. Mattinen, S.-L. Valle, S. Koskimies, G. Jung, and K. J. E. Krohn. 1993. Helper T-cell recognition of HIV-1 Tat synthetic peptides. J. Acquired Immune Defic. Syndr. 6:881-890.
3. Boshart, M., F. Weber, G. Jahu, K. Dorsch-Hlislov, B. Fleckenstein, and W. A. Schaffer. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
4. Conry, R. M., A. F. LoBuglio, J. Kantor, J. Schlom, F. Loechel, S. E. Moore, L. A. Sumerel, D. L. Barlow, S. Abrams, and D. T. Curiel. 1994. Immune response to carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54:1164-1168.
5. Cox, G. J. M., T. J. Zamb, and I. A. Babiuk. 1993. Bovine herpesvirus. I. Immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:5664-5667.
6. Czerkinsky, C., L. Å. Nilsson, H. Nygren, Ö. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
7. Davis, H. L., R. A. Demeneix, B. Quentin, J. Coulomb, and R. G. Wahlen. 1993. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:733-740.
8. Davis, H. L., M. L. Michel, and R. G. Wahlen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847-1851.
9. Eisenbraun, M. D., D. Heydenburg-Fuller, and J. R. Haynes. 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:791-797.
10. Estaquier, J., C. Boutillon, J.-C. Ameisen, H. Gras-Masse, A. Delanoye, J.-P. Lecocq, A. Dixson, A. Tartar, A. Capron, and C. Auriault. 1992. Determination of B-cell epitopes of nef HIV-1 protein: immunogenicity related to their structure. Mol. Immunol. 29:1337-1345.
11. Fynan, E. F., H. L. Robinson, and R. G. Webster. 1993. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12:785-789.
12. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. G. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
13. Goldstein, G. 1996. HIV-1 Tat protein as a potential AIDS vaccine. Nature Med. 2:960-963.
14. Gray, D., and H. Skervall. 1988. B-cell memory is short-lived in the absence of antigen. Nature 336:70-73.
15. Haynes, J. R., D. H. Fuller, M. D. Eisenbraun, M. J. Ford, and T. M. Pertmer. 1994. Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses. AIDS Res. Hum. Retroviruses 10:543-545.
16. Heydenburg-Fuller, D., and J. R. Haynes. 1994. A quantitative progression in HIV type 1 glycoprotein 120-specific cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10:1433-1441.
17. Hoffman, S. L., M. Sedegah, and R. C. Hedstrom. 1994. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 12:1529-1533.
18. Hohlfeld, R., and A. G. Engel. 1994. The immunobiology of muscle. Immunol. Today 15:269-274.
19. Justewicz, D. M., R. G. Webster, M. J. Morin, and H. L. Robinson. 1995. Localization of memory B-cell responses induced by DNA vaccine to the hemagglutinin of influenza virus in mice. Vaccines 95:77-83.
20. Kohleisen, B., K. Gaedigk-Nitschko, M. Ohlmann, E. Götz, H. Ostolaza, F. M. Goni, and V. Erfle. 1996. Heparin-binding capacity of the HIV-1 nef protein allows one-step purification and biochemical characterization. J. Virol. Methods 60:89-101.
21. Lukkonen, B. G. M., E. M. Fenyö, and S. Schwartz. 1995. Overexpression of the human immunodeficiency virus type 1 protease increases intracellular cleavage of gag and reduces virus infectivity. Virology 206:854-865.
22. Michel, F., A. Hoffenbach, P. Froussard, P. Langlade-Demoyen, M. Kaczorek, M. P. Kieny, and F. Plata. 1992. HIV-1 env, nef and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins. AIDS Res. Hum. Retroviruses 8:469-478.
23. Montagnier, L. 1995. Nef vaccination against HIV disease. Lancet 346:1170.
24. Montgomery, D. L., J. W. Shiver, K. R. Leander, H. C. Perrt, A. Friedman, D. Martinez, J. B. Ulmer, J. J. Donnelly, and M. A. Liu. 1993. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:777-783.
25. Moss, B. 1988. Use of vaccinia vectors for development of AIDS vaccines. AIDS 2:S103-S105.
26. Myers, G., S. Wain-Hobson, B. Korber, R. F. Smith, and C. N. Pavlakis (ed.). 1994. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N. Mex.
27. Okuda, K., H. Bukawa, K. Hamajima, S. Kawamoto, K.-I. Sekigawa, Y. Yamada, S.-I. Tanaka, N. Ishii, I. Aoki, M. Nakamura, H. Yamamoto, B. R. Cullen, and J. Fukushima. 1995. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res. Hum. Retroviruses 11:933-943.
28. Pedroza-Martins, L., L. L. Lau, M. Asano, and R. Ahmed. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574-2582.
29. Ranki, A., A. Lagerstedt, V. Ovod, E. Aavik, and K. J. E. Krohn. 1994. Expression kinetics and subcellular localization of HIV-1 regulatory proteins nef, tat and rev in acutely and chronically infected lymphoid cells. Arch. Virol. 139:365-378.
30. Rhodes, G. H., S. H. Gromkowski, S. E. Parker, M. Manthorpe, J. E. Morrow, N. Haigwood, D. J. Varavani, and P. L. Felgner. 1994. A novel method of inducing cellular and humoral immunity to HIV by DNA injection. AIDS Res. Hum. Retroviruses 199:132-140.
31. Richard, N., S. Iacampo, and A. Cochrane. 1994. HIV-1 rev is capable of shuttling between the nucleus and cytoplasm. Virology 204:123-131.
32. Robinson, H. L., I. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 11:957-960.
33. Sabatier, J.-M., B. Clerget-Raslain, G. Fontan, E. Fenouillet, H. Rochat, C. Granier, J.-C. Gluckman, J. Van Rietschoten, L. Montagnier, and E. Bahraoui. 1989. Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients. AIDS 3:215-220.
34. Sällberg, M., U. Ruden, L. O. Magnius, E. Norrby, and B. Wahren. 1991. Rapid tea-bag peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol. Lett. 30:59-68.
35. Schittek, B., and K. Rajewsky. 1990. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature 346:749-751.
36. Schneider, T., H.-P. Harthus, P. Hildebrandt, M. Niedrig, M. Bröker, W. Wiegelt, A. Beck, and G. Pauli. 1991. Epitopes of the HIV-1 negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1 positive sera. AIDS Res. Hum. Retroviruses 7:37-44.
37. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
38. Siakkou, H., S. Jahn, N. Kienzle, R. Ulrich, C. Grötzinger, T. Schneider, B. Kohleisen, G. Pauli, R. Spohn, G. Jung, N. Muller-Lantzsch, and D. H. Kruger. 1993. Fine mapping of HIV-1 nef epitopes by monoclonal antibodies. Arch. Virol. 128:81-95.
39. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwerki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
40. Ulmer, J. B., R. R. Deck, C. M. DeWitt, A. Friedman, J. J. Donnelly, and M. A. Liu. 1994. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541-1544.
41. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
42. Wang, B., J. Boyer, V. Srikantan, L. Coney, R. Carrano, C. Phan, M. Merva, K. Dang, M. Agadjanyan, K. Ugen, W. V. Williams, and D. B. Weiner. 1992. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 12:799-805.
43. Wang, B., M. Merva, K. Dang, K. E. Ugen, J. Boyer, W. V. Williams, and D. B. Weiner. 1994. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen expressing cells. AIDS Res. Hum. Retroviruses 10:535-541.
44. Webster, R. G., E. F. Fynan, J. C. Santoro, and H. L. Robinson. 1994. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12:1495-1498.
45. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
46. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. J. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132-140.
47. Xu, D., and F. Y. Liew. 1994. Genetic vaccination against leishmaniasis. Vaccine 12:1534-1536.
48. Yankauckas, M. A., J. E. Morrow, S. E. Parker, A. Abai, G. H. Rhodes, V. J. Dwarki, and S. H. Gromkowski. 1993. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12:771-776.
49. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocoriomeningitis virus infection. J. Virol. 69:2684-2688.